Emeryville, CA
The company is focused on developing innovative therapeutic solutions by utilizing a proprietary technology platform that measures the functional activity of antibodies. This approach aims to discover and create antibodies that not only block disease targets but also modulate their activity, addressing a wide range of untreated diseases including obesity, cancer, and inflammatory conditions. Their technology leverages synthetic biology and artificial intelligence to enhance the discovery process and has been validated through partnerships with pharmaceutical companies.
This business focuses on engineering medicine through a network biology approach rather than targeting individual biological components. It is developing a rapid transcriptomic sequencing platform to understand how chemical compounds interact with biological networks. The company is working on drug programs aimed at addressing drug resistance in chronic diseases such as cancer, chronic kidney disease, and neurodegeneration.
Cambridge, UK
This business develops innovative technologies for multiomic analysis, allowing researchers to capture both genetic and epigenetic information from a single sample in one experiment. Their products are designed to enhance understanding in various fields, including cancer research, neurodegenerative diseases, and precision medicine, by providing detailed insights into biological processes and disease mechanisms.
Berkeley, CA
This business specializes in advanced protein quantification technologies, particularly through its proprietary PIXI platform, which utilizes microfluidic gel technology for rapid and accurate protein measurement. The platform is designed for various applications, including biopharmaceutical analysis, cell and gene therapy, and synthetic biology, offering automated solutions that conserve sample volume and provide high sensitivity and reproducibility.
San Francisco, CA
This business focuses on developing nucleic acid medicines, including gene therapies and vaccines, by innovating how cells respond to DNA and mRNA. Their platform aims to enhance therapeutic outcomes by dampening undesirable cellular pathways, addressing both preventative and therapeutic vaccines, rare diseases, and gene therapy. The team is composed of visionary scientists dedicated to improving human health through foundational biological research.
Palo Alto, CA
This company is focused on developing innovative cell therapies for patients with late-stage liver disease, utilizing regenerative medicine technologies based on stem cells. Their goal is to provide alternatives to liver transplants, addressing the significant need for effective treatments as over 30 million Americans suffer from liver disease, with many facing end-stage liver failure. The company emphasizes a scalable manufacturing process that makes liver regeneration both clinically and economically viable.
San Diego, CA
This business utilizes a cutting-edge AI-driven platform to enhance drug discovery processes, focusing on solving complex design challenges and addressing unmet patient needs. Their approach includes high-throughput experimentation and physics-based AI algorithms to optimize drug candidates and target product profiles, ultimately aiming to deliver innovative therapeutics at a faster pace than industry standards.
This business specializes in engineered cell therapies, utilizing a patented non-viral technology called Hydropore™. This technology enables the rapid delivery of small molecules, nucleic acids, proteins, and gene-editing complexes to immune cells, significantly enhancing the efficiency of T-cell immunotherapies. The company focuses on providing scalable solutions for research and manufacturing, ensuring high-quality cell viability and function. Their offerings are designed to overcome the limitations of traditional viral transduction and electroporation methods, catering to biotech companies aiming to accelerate their research and development processes.
Southeast Minnesota
This biotechnology company specializes in developing living therapies for pets and humans, utilizing a proprietary platform that accelerates the design and testing of cancer cell therapies. Their innovative approach addresses the challenges in translating therapeutic proteins from digital designs into practical medical applications, aiming to revolutionize the field of regenerative medicine.
Nottingham, UK
This business specializes in integrated drug discovery services, offering a comprehensive range of solutions including target validation, hit identification, lead optimization, and formulation development. They cater to various therapeutic areas such as oncology, neuroscience, and metabolic diseases, utilizing advanced techniques in medicinal chemistry, bioscience, and computer-aided drug design. Their multi-disciplinary teams support clients throughout the drug development process, from initial research to regulatory submission.
South San Francisco, CA
This business specializes in single-cell technology that provides a multi-omics solution, enabling the simultaneous detection of single nucleotide variation (SNV), copy number variation (CNV), and protein data from individual cells. Their offerings are particularly focused on applications in oncology research, precision medicine, and cell and gene therapy, with a unique platform that enhances the understanding of tumor architecture and genetic diversity. They provide various products and services, including the Tapestri Platform and assay development for pharmaceutical applications.
Seattle, WA
This business specializes in advanced sequencing technology, specifically Duplex Sequencing®, which offers ultra-sensitive and accurate DNA sequencing with significantly reduced error rates. Their products include assays for acute myeloid leukemia (AML) and mutagenesis, as well as services for nitrosamine and mutagenesis testing. They target researchers and institutions in the fields of genomics and toxicology, providing tools that enhance the detection of rare genetic variants and improve the understanding of mutagenicity.
Newark, CA
This business specializes in in situ hybridization technologies, particularly focusing on RNA detection through various assays such as RNAscope™, BaseScope™, and miRNAscope™. They provide a range of products including target probes, assay kits, and automated systems, catering to research in fields like cancer, neuroscience, and gene therapy. Their services also include professional assay services and biomarker assay development, aimed at enhancing research and drug development processes.
San Diego, CA, USA
This business specializes in providing a vast array of small molecule libraries and building blocks for drug discovery and development. They offer over 1.3 million screening compounds, including lead-like and drug-like compounds, macrocycles, and custom libraries. Their services cater to various research needs, including diversity libraries, targeted specialty libraries for specific diseases, and reagents for hit-to-lead optimization. The company also features a large virtual database of synthetically accessible compounds to support research and development efforts.
This organization specializes in clinical research and development, offering services such as product development, regulatory consulting, and nonclinical early development. They focus on various therapeutic areas including oncology, rare diseases, cell and gene therapy, and pediatrics. Their target market includes biotech and specialty pharmaceutical companies, as well as medical device innovators, aiming to accelerate the path from innovative ideas to market-ready medical treatments.
Abingdon, Oxfordshire, UK
This platform serves as a leading resource for life science research, offering a wealth of information on various methodologies, news, and advancements in the field. It features articles, interviews, and multimedia content covering topics such as molecular biology, cancer research, microbiology, and drug discovery. The site also provides educational resources, including webinars and downloadable eBooks, aimed at researchers and professionals in the life sciences sector.
Cleveland, Ohio
This platform provides insights and updates on drug discovery and development, focusing on various therapeutic areas including oncology, neurological diseases, and infectious diseases. It features articles on recent advancements in pharmaceuticals, the impact of AI in drug development, and highlights significant events in the pharma industry. The site serves professionals in the pharmaceutical and biotechnology sectors, offering resources like podcasts, webinars, and reports on industry trends.
Uppsala, Sweden
This business specializes in high-throughput proteomics, offering advanced technology for protein biomarker analysis. Their services include a range of products such as customizable panels for protein biomarkers, software for data analysis, and analysis services. They target researchers and pharmaceutical companies, focusing on applications in disease research, drug development, and personalized medicine. Their unique Proximity Extension Assay (PEA) technology allows for scalable and specific protein analysis, facilitating significant advancements in biomarker discovery and clinical utility.
Hasselt, Belgium
This business specializes in providing automation solutions for molecular laboratories, enhancing sample flow management, real-time quality control, and operational insights through a comprehensive software platform. Their offerings include tools for clinical diagnostics, veterinary diagnostics, and pharmaceutical applications, focusing on improving lab efficiency and accuracy in result calling. The platform integrates various laboratory technologies and provides a user-friendly interface for lab personnel.
Cambridge, Massachusetts
This company specializes in pioneering mRNA technology to develop innovative medicines and vaccines. Their approach focuses on utilizing messenger RNA to instruct cells to produce proteins that can prevent or treat diseases, offering a new paradigm in medicine. They have a robust pipeline of products, including vaccines for COVID-19, and emphasize rapid development and accessibility of their treatments. The company also highlights its commitment to sustainability and social responsibility, aiming to make medicines available without animal products or preservatives.